Phase I study of recombinant human interleukin-1β (rhIL-1β) in patients with bone marrow failure
Nemunaitis, J.; Ross, M.; Meisenberg, B.; Oreilly, R.; Lilleby, K.; Buckner, C.D.; Appelbaum, F.R.; Buhles, W.; Singer, J.; Peters, W.P.
Bone Marrow Transplantation (Basingstoke) 14(4): 583-588
1994
ISSN/ISBN: 0268-3369 Accession: 077180679
Full Text Article emailed within 1 workday: $29.90
Related References
Fujii, Y.; Imamura, M.; Hashino, S.; Kobayashi, H.; Kobayashi, M.; Kasai, M.; Sakurada, K.; Miyazaki, T. 1992: Therapy with cytokines and biological response modifiers brms prior to syngeneic bone marrow transplantation in mice effect of recombinant human interleukin 1 beta rhil 1 beta interleukin 2 rhil 2 interleukin 6 rhil 6 recombinant murine tumor necrosis factor alpha rmtnf alpha and chinese herbal medicine ninjin youei to nyt on immunohematologic reconstitution Biomedicine and Pharmacotherapy 46(5-7): 315Nemunaitis, J.; Ross, M.; Meisenberg, B.; O'Reilly, R.; Lilleby, K.; Buckner, C.D.; Appelbaum, F.R.; Buhles, W.; Singer, J.; Peters, W.P. 1994: Phase i study of recombinant human interleukin-1 beta (rhIL-1 beta) in patients with bone marrow failure Bone Marrow Transplantation 14(4): 583-588
Clutterbuck, E.J.; Sanderson, C.J. 1990: Regulation of human eosinophil precursor production by cytokines: a comparison of recombinant human interleukin-1 (rhIL-1), rhIL-3, rhIL-5, rhIL-6, and rh granulocyte-macrophage colony-stimulating factor Blood 75(9): 1774-1779
Orazi, A.; Cooper, R.J.; Tong, J.; Gordon, M.S.; Battiato, L.; Sledge, G.W.; Kaye, J.A.; Kahsai, M.; Hoffman, R. 1996: Effects of recombinant human interleukin-11 (Neumega rhIL-11 growth factor) on megakaryocytopoiesis in human bone marrow Experimental Hematology 24(11): 1289-1297
Kurzrock, R.; Talpaz, M.; Estrov, Z.; Rosenblum, M.G.; Gutterman, J.U. 1991: Phase i study of recombinant human interleukin-3 in patients with bone marrow failure Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 9(7): 1241-1250
Aoki, I.; Homori, M.; Nakahara, K.; Higashi, K.; Ishikawa, K. 1995: Effects of rhIL-1 alpha, rhIL-1 beta, and rhIL-1 receptor antagonist on erythroid progenitors (CFU-E and BFU-E) in human bone marrow Experimental Hematology 23(3): 217-225
Mumcuoglu, M.; Slavin, S. 1999: Enhancement of hematopoietic reconstitution with recombinant cytokines: effect of rhIL-6 in combination with rhGM-CSF and rhIL-3 on unmodified or T cell-depleted bone marrow Journal of HematoTherapy 8(3): 247-253
List, A.F.; Hersh, E.M.; Taetle, R.; Rinehart, J.; Quick, D.; Neidhart, J.A. 1992: Phase i ii trial of subcutaneous recombinant interleukin 3 in patients with bone marrow failure Proceedings of the American Association for Cancer Research 33: 243
Winton, E.F.; Srinivasiah, J.; Kim, B.K.; Hillyer, C.D.; Strobert, E.A.; Orkin, J.L.; Swenson, R.B.; McClure, H.M.; Myers, L.A.; Saral, R. 1994: Effect of recombinant human interleukin-6 (rhIL-6) and rhIL-3 on hematopoietic regeneration as demonstrated in a nonhuman primate chemotherapy model Blood 84(1): 65-73
Ganser A.; Ottmann O.G.; Seipelt G.; Eder M.; Lindemann A.; Becher R.; Hoeffken K.; Buechner T.; Mertelsmann R.; Et Al 1990: Recombinant human interleukin 3 rhil 3 in myelodysplastic syndromes mds results of a phase i ii trial Proceedings of the American Association for Cancer Research 31: 195
Modi M.; Nadeau R.; Ni Wu G.; Della Valle C.; Olejnik N.; Hayes T.; Liberato D. 1991: The pharmacokinetics of recombinant human interleukin 1 alpha rhil 1 alpha in rats that received single ascending intravenous doses of rhil 1 alpha and the resultant dose dependent concentrations of endogenous serum interleukin 6 il 6 FASEB Journal 5(6): A1567
Fujii, Y.; Imamura, M.; Hashino, S.; Kobayashi, H.; Kobayashi, M.; Sakurada, K.; Miyazaki, T.; Hori, K. 1991: Effects of recombinant human interleukin 1 beta recombinant human interleukin 2 and recombinant murine tumor necrosis factor alpha on the reconstitution of hematopoiesis and immune functions in lethally irradiated mice transplanted with syngeneic bone marrow cells Miyazaki, T , F Takaku And H Uchino (Ed ) International Congress Series, 956 Myelodysplastic Syndrome And Cytokines; International Symposium, Sapporo, Japan, September 28-29, 1990 Xii+325p Elsevier Science Publishers B V : Amsterdam, Netherlands; (Dist in The Usa And Canada By Elsevier Science Publishing Co , Inc : New York, New York) Illus 191-194
Kevin, G. Waddick; Dr. Fatih, M. Uckun 1993: Effects of Recombinant Interleukin-3 and Recombinant Interleukin-6 on Radiation Survival of Normal Human Bone Marrow Progenitor Cells Radiation Oncology Investigations 1(1): 34-40
Gordon, M.S.; McCaskill-Stevens, W.J.; Battiato, L.A.; Loewy, J.; Loesch, D.; Breeden, E.; Hoffman, R.; Beach, K.J.; Kuca, B.; Kaye, J.; Sledge, G.W. 1996: A phase I trial of recombinant human interleukin-11 (neumega rhIL-11 growth factor) in women with breast cancer receiving chemotherapy Blood 87(9): 3615-3624
Harousseau, J.L.; Attal, M.; De Cervens, C.; Sumar, D.; Girault, D.; Gianella Boradori, A. 1994: Phase I/II trial of recombinant human interleukin-6 and GMCSF following autologous bone marrow transplantation for non Hodgkin lymphoma British Journal of Haematology 87(Suppl 1): 36
Elkordy, M.; Crump, M.; Coniglio, D.; Rabinowitz, J.; Laughlin, M.; Kurtzberg, J.; Peters, W.P.; Vredenburgh, J.J.; Petros, W.P.; Hussein, A.; Rubin, P.; Ross, M.; Gilbert, C.; Modlin, C.; Meisenberg, B. 1997: A phase I trial of recombinant human interleukin-1β (OCT-43) following high-dose chemotherapy and autologous bone marrow transplantation Bone Marrow Transplantation (Basingstoke) 19(4): 315-322
Nemunaitis, J.; Appelbaum, F.R.; Singer, J.W.; Lilleby, K.; Wolff, S.; Greer, J.P.; Bierman, P.; Resta, D.; Campion, M.; Levitt, D. 1993: Phase i trial with recombinant human interleukin-3 in patients with lymphoma undergoing autologous bone marrow transplantation Blood 82(11): 3273-3278
Givon, T.; Revel, M.; Slavin, S. 1994: Potential use of interleukin-6 in bone marrow transplantation: effects of recombinant human interleukin-6 after syngeneic and semiallogeneic bone marrow transplantation in mice Blood 83(6): 1690-1697
Elkordy, M.; Crump, M.; Vredenburgh, J.J.; Petros, W.P.; Hussein, A.; Rubin, P.; Ross, M.; Gilbert, C.; Modlin, C.; Meisenberg, B.; Coniglio, D.; Rabinowitz, J.; Laughlin, M.; Kurtzberg, J.; Peters, W.P. 1997: A phase I trial of recombinant human interleukin-1-beta (OCT-43) following high-dose chemotherapy and autologous bone marrow transplantation Bone Marrow Transplantation 19(4): 315-322
Elkordy, M.; Crump, M.; Vredenburgh, J.J.; Petros, W.P.; Hussein, A.; Rubin, P.; Ross, M.; Gilbert, C.; Modlin, C.; Meisenberg, B.; Coniglio, D.; Rabinowitz, J.; Laughlin, M.; Kurtzberg, J.; Peters, W.P. 1997: A phase I trial of recombinant human interleukin-1 beta (OCT-43) following high-dose chemotherapy and autologous bone marrow transplantation Bone Marrow Transplantation 19(4): 315-322